Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Draupnir Bio ApS
APS
Active
Reklamebeskyttelse
CVR 38546880
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 9 years old
12 employees
www.draupnir.bio
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Draupnir Bio ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
AT
Andrew Thomas Hotchkiss
Management
Management
2021
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (6)
SE
Stefan Emanuel Luzi
Board of Directors
Board of Directors
2019
IB
Ivan Burkov
Board of Directors
Board of Directors
2022
EC
Emmanuelle Coutanceau
Board of Directors
Board of Directors
2021
SG
Simon Glerup Pedersen
Board of Directors
Board of Directors
2019
RA
Robert Andrew Donald Scott
Board of Directors
Board of Directors
2020
EC
Eva-Lotta Coulter
Chairman
Chairman
2021
Former (5)
PS
Peder Søndergaard Madsen
Chairman
Chairman
2017 – 2018
FM
Fiona MacLaughlin
Board of Directors
Board of Directors
2019 – 2020
CG
Camilla Gustafsen
Board of Directors
Board of Directors
2017 – 2018
RB
Roel Bulthuis
Board of Directors
Board of Directors
2020 – 2022
PH
Peter Hans Andreas Seeberger
Board of Directors
Board of Directors
2018 – 2019
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Novo Holdings A/S
Company
20–24.99%
20–24.99%
2024
Stichting Depositary INKEF Investment Fund
Individual
20–24.99%
20–24.99%
2024
Coöperatieve Gilde Healthcare IV U.A.
Individual
20–24.99%
20–24.99%
2024
Danmarks Eksport- og Investeringsfond
Company
10–14.99%
10–14.99%
2024
MP Healthcare Venture Management, Inc,
Individual
10–14.99%
10–14.99%
2024
High-Tech Gründerfonds III GmbH & Co. KG
Individual
5–9.99%
5–9.99%
2019
Seeberger Science GmbH
Individual
5–9.99%
5–9.99%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Draupnir Bio ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network